Next, we evaluated whether p65 and p50 nuclear translocation in doxorubicin-treated tumor specimens was associated with an increase in the expression of NF-κB target genes TNFAIP3, ICAM-1 and CXCL-1. This evidence concerns the gene CXCL1 and neoplasm.